Perrigo plans to separate prescription pharma business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Mylan N.V. (MYL) Announces U.S. Launch of Tadalafil Tablets USP 20mg, First Generic for Eli Lilly's (LLY) Adcirca Tablets
August 13, 2018 11:06 AM EDTGlobal pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first generic version of the reference listed drug, Eli Lilly and... More
Cantor Fitzgerald Remains Bullish on Perrigo (PRGO) Despite Guidance Cut
August 9, 2018 11:22 AM EDTCantor Fitzgerald analsyt Louise Chen remains positive on Perrigo Co. (NYSE: PRGO) despite lowered FY18 guidance.
Chen notes weakness was driven by headwinds in its Rx business, which it now expects to sell, merge or separate out in 2H19.... More
